These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30078201)

  • 21. Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidants as therapy for Parkinson's disease.
    Shults CW
    Antioxid Redox Signal; 2005; 7(5-6):694-700. PubMed ID: 15890014
    [No Abstract]   [Full Text] [Related]  

  • 23. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
    Schapira AH; Olanow CW; Greenamyre JT; Bezard E
    Lancet; 2014 Aug; 384(9942):545-55. PubMed ID: 24954676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective therapy for Parkinson's disease.
    Koller WC
    Exp Neurol; 1997 Mar; 144(1):24-8. PubMed ID: 9126147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroinflammation in Parkinson's disease: a target for neuroprotection?
    Hirsch EC; Hunot S
    Lancet Neurol; 2009 Apr; 8(4):382-97. PubMed ID: 19296921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling.
    Baluchnejadmojarad T; Jamali-Raeufy N; Zabihnejad S; Rabiee N; Roghani M
    Eur J Pharmacol; 2017 Apr; 801():72-78. PubMed ID: 28284752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urate in Parkinson's disease: more than a biomarker?
    Chen X; Wu G; Schwarzschild MA
    Curr Neurol Neurosci Rep; 2012 Aug; 12(4):367-75. PubMed ID: 22580741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kynurenines in Parkinson's disease: therapeutic perspectives.
    Zádori D; Klivényi P; Toldi J; Fülöp F; Vécsei L
    J Neural Transm (Vienna); 2012 Feb; 119(2):275-83. PubMed ID: 21858430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
    Singh S; Mishra A; Shukla S
    Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marine-Derived Natural Compounds for the Treatment of Parkinson's Disease.
    Huang C; Zhang Z; Cui W
    Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 30978965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective strategies in Parkinson's disease : an update on progress.
    Mandel S; Grünblatt E; Riederer P; Gerlach M; Levites Y; Youdim MB
    CNS Drugs; 2003; 17(10):729-62. PubMed ID: 12873156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway.
    Huang TT; Hao DL; Wu BN; Mao LL; Zhang J
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1443-1449. PubMed ID: 28986252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective potential of spermidine against rotenone induced Parkinson's disease in rats.
    Sharma S; Kumar P; Deshmukh R
    Neurochem Int; 2018 Jun; 116():104-111. PubMed ID: 29501454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions.
    Michel HE; Tadros MG; Esmat A; Khalifa AE; Abdel-Tawab AM
    Mol Neurobiol; 2017 Sep; 54(7):4866-4878. PubMed ID: 27514753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nur77 attenuates inflammatory responses and oxidative stress by inhibiting phosphorylated IκB-α in Parkinson's disease cell model.
    Yan J; Huang J; Wu J; Fan H; Liu A; Qiao L; Shen M; Lai X
    Aging (Albany NY); 2020 May; 12(9):8107-8119. PubMed ID: 32401747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress and neurodegenerative diseases: looking for a therapeutic solution inspired on benzopyran chemistry.
    Gaspar A; Milhazes N; Santana L; Uriarte E; Borges F; Matos MJ
    Curr Top Med Chem; 2015; 15(5):432-45. PubMed ID: 25658803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotection for Parkinson's disease: a new approach for a new millennium.
    Drukarch B; van Muiswinkel FL
    Expert Opin Investig Drugs; 2001 Oct; 10(10):1855-68. PubMed ID: 11772291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.
    Vivekanantham S; Shah S; Dewji R; Dewji A; Khatri C; Ologunde R
    Int J Neurosci; 2015; 125(10):717-25. PubMed ID: 25364880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.